Clinical Trials Logo

Clinical Trial Summary

A cross-sectional survey will be conducted among 200 volunteering women aged 18- 45 years and having had prior sexual activity living in the target villages of Itilima and Maswa districts, North-western Tanzania. A single midday urine sample and two cervical-vaginal swabs (both self-collected and speculum-aided collected by a female healthcare worker) will be obtained from participating women and processed using urine filtration and polymerase chain reaction (PCR) for cervico-vaginal samples. A pre-tested structure questionnaire will be used to collect sociodemographic, clinical, and sampling acceptability information from participants.


Clinical Trial Description

A cross-sectional survey will be conducted among 200 volunteering women aged 18-45 years and having had prior sexual activity living in the target villages of Itilima and Maswa districts, North-western Tanzania. A single midday urine sample and two cervical-vaginal swabs (both self-collected and speculum-aided collected by a female healthcare worker) will be obtained from participating women and processed using urine filtration and polymerase chain reaction (PCR) for cervico-vaginal samples. A pre-tested structure questionnaire will be used to collect sociodemographic, clinical, and sampling acceptability information from participants. Prevalence of Female Genital Schistosomiasis (FGS) will be estimated based on positivity of at least one genital specimen. Quantitative data will be described using means/medians and standard deviation/interquartile range, as appropriate. Qualitative data will be described as numbers and percentages, and compared using Chi-squared or Fisher Exact test, as appropriate. Sensitivity of the two genital sampling methods will be compared using the composite reference constituted by positivity in at least one genital swab, and the performance of the two methods compared using Cohen's Kappa statistics, Fisher's Exact test and parametric/nonparametric test for comparison of PCR Ct values, as appropriate. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05788003
Study type Interventional
Source IRCCS Sacro Cuore Don Calabria di Negrar
Contact
Status Active, not recruiting
Phase N/A
Start date July 4, 2022
Completion date March 17, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06055530 - Evaluation of an AI-DP for STH Deworming Programs: a Study Protocol
Completed NCT02878564 - Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology Phase 4
Completed NCT00403611 - Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Brazil Phase 4
Recruiting NCT05658614 - Anti-Schistosomiasis Sm14-vaccine in Senegal Phase 2
Completed NCT01931826 - Treatment Schistosomal Portal Hypertension: Efficacy of Endoscopy or Surgery N/A
Recruiting NCT03640377 - Praziquantel in Children Under Age 4 Phase 2
Completed NCT01529710 - Safety and Efficacy of Mirazid for Schistosomiasis Treatment Phase 3
Completed NCT04269915 - Single-sex Female Controlled Human Schistosomiasis Mansoni Infection N/A
Completed NCT00463307 - Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in Kenya N/A